Trials / Completed
CompletedNCT00380601
PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)
An Open-label, PhaseⅢ Study to Evaluate the Efficacy and Safety of MRA in Patients With RA
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Chugai Pharmaceutical · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
An open-label, PhaseⅢ study to evaluate the efficacy and safety of MRA in patients with RA
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MRA(Tocilizumab) | 8mg/kg/4 weeks |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2008-08-01
- Completion
- 2009-02-01
- First posted
- 2006-09-26
- Last updated
- 2009-12-23
Locations
10 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00380601. Inclusion in this directory is not an endorsement.